Nicotredole

Nicotredole

SCHEMBL2544181

O=C(NCCc1c[nH]c2ccccc12)c1cccnc1.O=C(O)CNC(=O)/C=C/c1ccccc1

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.72
KMT2A Q03164 2/20 0.72
CDK4 P11802 2/20 0.61
CCND1 P24385 2/20 0.61
NAMPT P43490 6/20 0.58
NPC1 O15118 1/20 0.58
RAB9A P51151 1/20 0.58
GAA P10253 1/20 0.57
HPGD P15428 1/20 0.57
SIRT2 Q8IXJ6 1/20 0.55
ALDH1A1 P00352 1/20 0.54
GLA P06280 1/20 0.54
HDAC1 Q13547 1/20 0.53
GSK3B P49841 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
PTGS2 P35354 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nicotredole SCHEMBL29454469 0.85 MEN1 (1.00) MEN1KMT2ACDK4CCND1NPC1
Nicotredole SCHEMBL735897 0.85 MEN1 (1.00) MEN1KMT2ACDK4CCND1NPC1
SCHEMBL27488695 0.81 SIRT2 (0.74) MEN1KMT2ANPC1RAB9ASIRT2
SCHEMBL27488694 0.81 SIRT2 (0.74) MEN1KMT2ANPC1RAB9ASIRT2
SCHEMBL13949881 0.78 HDAC1 (0.68) MEN1KMT2ANAMPTHDAC1
Behenic Acid SCHEMBL4075758 0.78 MEN1 (0.76) MEN1KMT2ACDK4CCND1NPC1
SCHEMBL8246681 0.77 HDAC3 (0.71) MEN1KMT2ACDK4CCND1NPC1
Nicotredole SCHEMBL17824507 0.76 MEN1 (0.81) MEN1KMT2ACDK4CCND1NPC1
SCHEMBL4331421 0.76 MEN1 (1.00) MEN1KMT2ACDK4CCND1NPC1
SCHEMBL13942359 0.75 CDK4 (0.83) MEN1KMT2ACDK4CCND1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9168316-B2 Methods for treating obesity GU YANSONG (US) 2015-10-27 US claimed
US-20140322136-A1 METHODS FOR TREATING OBESITY GU YANSONG (US) 2014-10-30 US claimed
US-20110262362-A1 METHODS FOR TREATING OBESITY GU YANSONG 2011-10-27 US claimed
WO-2010042868-A2 METHODS FOR TREATING OBESITY UNIVERSITY OF WASHINGTON (US) 2010-04-15 WO claimed
EP-3190109-B1 INDOLE AMIDE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES UNIV LEUVEN KATH (BE) 2020-02-19 EP disclosed
US-9168316-B2 Methods for treating obesity GU YANSONG (US) 2015-10-27 US disclosed
US-8980852-B2 Methods for treating obesity GU YANSONG (US) 2015-03-17 US disclosed
US-20140322136-A1 METHODS FOR TREATING OBESITY GU YANSONG (US) 2014-10-30 US disclosed
US-20110262362-A1 METHODS FOR TREATING OBESITY GU YANSONG 2011-10-27 US disclosed
WO-2010042868-A2 METHODS FOR TREATING OBESITY UNIVERSITY OF WASHINGTON (US) 2010-04-15 WO disclosed